Search Results
Results for: ALL (Save this search)
Number of Results: 1000
Kraft Heinz to Acquire Primal Kitchen for USD 200m
30 November 2018 - Pennsylvania, US-based food and beverage company Kraft Heinz Company (NASDAQ: KHC) has agreed to acquire California, US-based Primal Nutrition, LLC, makers of Pr...

MIROMA GROUP ACQUIRES UK-BASED WAY TO BLUE COMMUNICATIONS AGENCY
UK-based communications company The Miroma Group (Miroma) has entered into an agreement to acquire UK-based global integrated communications agency Way to&...

MIROMA GROUP ACQUIRES UK-BASED WAY TO BLUE COMMUNICATIONS AGENCY
UK-based communications company The Miroma Group (Miroma) has entered into an agreement to acquire UK-based global integrated communications agency Way to&...

GENEREX BIOTECHNOLOGY ACQUIRES 51% OF REGENTYS TO EXPAND MEDICAL DEVICE/WOUND CARE PORTFOLIO
Florida, US-based Generex biotechnology Corp. has signed a binding letter of intent (LOI) to acquire 51% of regenerative medicine company Regentys Corp., developer of Extra-Cellula...

GENEREX BIOTECHNOLOGY ACQUIRES 51% OF REGENTYS TO EXPAND MEDICAL DEVICE/WOUND CARE PORTFOLIO
Florida, US-based Generex biotechnology Corp. has signed a binding letter of intent (LOI) to acquire 51% of regenerative medicine company Regentys Corp., developer of Extra-Cellula...

GENEREX BIOTECHNOLOGY ACQUIRES 51% OF REGENTYS TO EXPAND MEDICAL DEVICE/WOUND CARE PORTFOLIO
Florida, US-based Generex biotechnology Corp. has signed a binding letter of intent (LOI) to acquire 51% of regenerative medicine company Regentys Corp., developer of Extra-Cellula...

GENEREX BIOTECHNOLOGY ACQUIRES 51% OF REGENTYS TO EXPAND MEDICAL DEVICE/WOUND CARE PORTFOLIO
Florida, US-based Generex biotechnology Corp. has signed a binding letter of intent (LOI) to acquire 51% of regenerative medicine company Regentys Corp., developer of Extra-Cellula...

GENEREX BIOTECHNOLOGY ACQUIRES 51% OF REGENTYS TO EXPAND MEDICAL DEVICE/WOUND CARE PORTFOLIO
Florida, US-based Generex biotechnology Corp. has signed a binding letter of intent (LOI) to acquire 51% of regenerative medicine company Regentys Corp., developer of Extra-Cellula...

GENEREX BIOTECHNOLOGY ACQUIRES 51% OF REGENTYS TO EXPAND MEDICAL DEVICE/WOUND CARE PORTFOLIO
Florida, US-based Generex biotechnology Corp. has signed a binding letter of intent (LOI) to acquire 51% of regenerative medicine company Regentys Corp., developer of Extra-Cellula...

You can compare news articles by clicking on the tick buttons
<  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54   55   56   57   58   59   60   61   62   63   64   65   66   67   68   69   70   71   72   73   74   75   76   77   78   79   80   81   82   83   84   85   86   87   88   89   90   91   92   93   94   95   96   97   98   99   100   >